Wells Fargo
HCAT icon

Wells Fargo’s Health Catalyst HCAT Stock Holding History

Wells Fargo’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.51K Sell
1,763
-24,864
-93% -$35.9K ﹤0.01% 6288
2026
Q1 		$33.8K Sell
26,627
-53,705
-67% -$101K ﹤0.01% 5581
2025
Q4 		$192K Sell
80,332
-6,951
-8% -$19K ﹤0.01% 5090
2025
Q3 		$249K Buy
87,283
+37,883
+77% +$130K ﹤0.01% 4808
2025
Q2 		$186K Buy
49,400
+9,105
+23% +$35.8K ﹤0.01% 4814
2025
Q1 		$183K Buy
40,295
+940
+2% +$4.97K ﹤0.01% 4773
2024
Q4 		$278K Buy
39,355
+8,451
+27% +$67.3K ﹤0.01% 4584
2024
Q3 		$252K Buy
30,904
+4,686
+18% +$33.9K ﹤0.01% 4420
2024
Q2 		$168K Buy
26,218
+1,665
+7% +$10.7K ﹤0.01% 4629
2024
Q1 		$185K Buy
24,553
+2,559
+12% +$23.4K ﹤0.01% 4518
2023
Q4 		$204K Buy
21,994
+6,487
+42% +$53K ﹤0.01% 4453
2023
Q3 		$157K Sell
15,507
-7,542
-33% -$90K ﹤0.01% 4506
2023
Q2 		$288K Buy
23,049
+12,619
+121% +$150K ﹤0.01% 4351
2023
Q1 		$122K Buy
10,430
+10,094
+3,004% +$129K ﹤0.01% 4711
2022
Q4 		$3.57K Sell
336
-214
-39% -$2.07K ﹤0.01% 5864
2022
Q3 		$5K Sell
550
-1,664
-75% -$22K ﹤0.01% 5903
2022
Q2 		$31K Sell
2,214
-20,081
-90% -$342K ﹤0.01% 5251
2022
Q1 		$582K Sell
22,295
-16,881
-43% -$479K ﹤0.01% 4307
2021
Q4 		$1.55M Buy
39,176
+22,381
+133% +$1.02M ﹤0.01% 3741
2021
Q3 		$840K Buy
16,795
+13,876
+475% +$757K ﹤0.01% 4355
2021
Q2 		$162K Sell
2,919
-29,341
-91% -$1.56M ﹤0.01% 5119
2021
Q1 		$1.51M Sell
32,260
-56,825
-64% -$2.75M ﹤0.01% 3938
2020
Q4 		$3.88M Sell
89,085
-2,336,749
-96% -$86.2M ﹤0.01% 2974
2020
Q3 		$88.8M Buy
2,425,834
+1,927,190
+386% +$65.4M 0.02% 614
2020
Q2 		$14.5M Sell
498,644
-612,811
-55% -$16.9M ﹤0.01% 1577
2020
Q1 		$29.1M Buy
1,111,455
+927,194
+503% +$28.3M 0.01% 1043
2019
Q4 		$6.39M Sell
184,261
-424,926
-70% -$14.1M ﹤0.01% 2345
2019
Q3 		$19.3M Buy
+609,187
New +$24M 0.01% 1461

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo's HCAT Position: Q2 2026 in Review

Wells Fargo reduced its Health Catalyst (HCAT) stake by 93% in Q2 2026, selling an estimated $35.9K and leaving 1,763 shares worth $3.51K. The position accounts for ﹤0.01% of the portfolio, ranked #6288.

Wells Fargo first reported a position in HCAT in Q3 2019 and has held it in 28 quarters since. The position peaked at $88.8M in Q3 2020. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Wells Fargo held 1,763 shares of Health Catalyst worth $3.51K as of Q2 2026.
  • Wells Fargo sold 24,864 Health Catalyst shares in Q2 2026, an estimated $35.9K.
  • Health Catalyst made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6288 holding.
  • Wells Fargo first reported a position in Health Catalyst in Q3 2019 and has held it in 28 quarters since.
  • Wells Fargo's Health Catalyst position peaked at $88.8M in Q3 2020.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.